Clinical Trials Directory

Trials / Unknown

UnknownNCT05607940

Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery

A Multi-center, Single Blinded Randomized Trial Investigating Indications Based Blood Transfusion Practices in Patients With Major Oncological Surgery

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
260 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Investigators aimed to compare the effect on different indications (blood volume loss based VS hemoglobin concentration based ) based blood transfusion practices in patients undergoing major oncological surgery for pelvic or spinal tumor and investigate their postoperative complications.

Detailed description

260 patients underwent major oncological surgery for open pelvic or spinal tumor resection were included in this study. We looked at white blood cells, hemoglobin, hematocrit, neutrophil ratio, C-reactive protein, erythrocyte sedimentation rate, and IL-6 levels 1 day, 3 days, and 7 days after surgery The main question it sought to answer was whether there was a difference in postoperative complications 30 days after surgery between patients who received blood transfusions based on volume loss and those who received blood transfusions based on hemoglobin concentration during surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREblood volume loss based blood transfusionBlood transfusion is indicated based on the estimated intraoperative blood loss. When intraoperative blood loss exceeds 400ml, blood transfusion begin. At the end of the operation, we ensure that the volume of blood transfusion is no greater than the anticipated blood loss.
PROCEDUREhemoglobin concentration based blood transfusionBlood transfusion is indicated based on the intraoperative hemoglobin concentration. Intraoperative blood transfusion begins when hemoglobin concentration is blow 70g/L. Intraoperative blood transfusion stops when hemoglobin concentration reaches 80g/L

Timeline

Start date
2023-01-01
Primary completion
2025-06-01
Completion
2025-12-01
First posted
2022-11-07
Last updated
2022-11-07

Source: ClinicalTrials.gov record NCT05607940. Inclusion in this directory is not an endorsement.